 |
 |

Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons
A. C. G. Voordouw, MD;
M. C. J. M. Sturkenboom, PhD;
J. P. Dieleman, PhD;
Th. Stijnen, PhD;
D. J. Smith, PhD;
J. van der Lei, PhD;
Bruno H. Ch. Stricker, MB, PhD
JAMA. 2004;292:2089-2095.
Context Although large-scale observational studies have demonstrated the effectiveness of influenza vaccination, no large studies have systematically addressed the clinical benefit of annual revaccinations.
Objective To investigate the effect of annual influenza revaccination on mortality in community-dwelling elderly persons.
Design, Setting, and Participants A population-based cohort study using the computerized Integrated Primary Care Information (IPCI) database in the Netherlands including community-dwelling individuals aged 65 years or older from 1996 through 2002. For each year, we computed the individual cumulative exposure to influenza vaccination since study start.
Main Outcome Measure Association between the number of consecutive influenza vaccinations and all-cause mortality vs no vaccination after adjusting for age, sex, chronic respiratory and cardiovascular disease, hypertension, diabetes mellitus, renal failure, and cancer.
Results The study population included 26 071 individuals, of whom 3485 died during follow-up. Overall, a first vaccination was associated with a nonsignificant annual reduction of mortality risk of 10% (hazard ratio [HR], 0.90; 95% confidence interval [CI], 0.78-1.03) while revaccination was associated with a reduced mortality risk of 24% (HR, 0.76; 95% CI, 0.70-0.83). Compared with a first vaccination, revaccination was associated with a reduced annual mortality risk of 15% (HR, 0.85; 95% CI, 0.75-0.96). During the epidemic periods this reduction was 28% (HR, 0.72; 95% CI, 0.53-0.96). Similar estimates were obtained for persons with and without chronic comorbidity and those aged 70 years or older at baseline. Overall, influenza vaccination is estimated to prevent 1 death for every 302 vaccinees at a vaccination coverage that varied between 64% and 74%.
Conclusion Annual influenza vaccination is associated with a reduction in all-cause mortality risk in a population of community-dwelling elderly persons, particularly in older individuals.
Author Affiliations: Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology & Biostatistics (Drs Voordouw, Sturkenboom, Dieleman, Stijnen, and Stricker), Department of Medical Informatics (Drs Sturkenboom, Dieleman, and van der Lei), and Department of Virology (Dr Smith), Erasmus University Medical Center, Rotterdam, the Netherlands; Medicines Evaluation Board (Dr Voordouw) and DrugSafety Unit, Inspectorate for Health Care (Dr Stricker), the Hague, the Netherlands; and Department of Zoology, University of Cambridge, Cambridge, England (Dr Smith).
RELATED ARTICLE
Influenza
Janet M. Torpy, Tiffany J. Glass, and Richard M. Glass
JAMA. 2004;292(17):2182.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area
Ortqvist et al.
Eur Respir J 2007;30:414-422.
ABSTRACT
| FULL TEXT
Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia.
Voordouw et al.
Arch Intern Med 2006;166:1980-1985.
ABSTRACT
| FULL TEXT
Interdisciplinary Epidemiologic and Economic Research Needed to Support a Universal Childhood Influenza Vaccination Policy
Coleman et al.
Epidemiol Rev 2006;28:41-46.
ABSTRACT
| FULL TEXT
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson et al.
Int J Epidemiol 2006;35:337-344.
ABSTRACT
| FULL TEXT
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
Jackson et al.
Int J Epidemiol 2006;35:345-352.
ABSTRACT
| FULL TEXT
A Technical Infrastructure to Conduct Randomized Database Studies Facilitated by a General Practice Research Database
Mosis et al.
J. Am. Med. Inform. Assoc. 2005;12:602-607.
ABSTRACT
| FULL TEXT
Influenza Vaccine Confusion: A Call for an Alternative Evidence-Based Approach
Yogev
Pediatrics 2005;116:1214-1215.
FULL TEXT
Influenza Vaccination Among Diabetic Adults: Related factors and trend from 1993 to 2001 in Spain
Jimenez-Garcia et al.
Diabetes Care 2005;28:2031-2033.
FULL TEXT
Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
Longini and Halloran
Am J Epidemiol 2005;161:303-306.
ABSTRACT
| FULL TEXT
Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
Simonsen et al.
Arch Intern Med 2005;165:265-272.
ABSTRACT
| FULL TEXT
Mortality Benefit of Repeat Flu Vaccination in Elders
Journal Watch Cardiology 2004;2004:5-5.
FULL TEXT
Mortality Benefit of Repeat Flu Vaccination in Elders
JWatch General 2004;2004:1-1.
FULL TEXT
|